ProPhase Labs, Inc.
(NASDAQ: PRPH)

ProPhase Labs, Inc. is a manufacturer, marketer and distributor of a ranges of homeopathic and health products that are offered to the general public. The Company is also engaged in the research and development of potential over-the-counter (OTC) drugs, natural base health products along with supplements, personal care and cosmeceutical products. The Company's primary business is manufacturing, distribution, marketing and selling of OTC cold remedy products to consumers through food, multi-outlet pharmacy and chain drug stores, wholesalers and mass merchandisers. The Company's brand is Cold-EEZEO Cold Remedy and the Company's principal product is Cold-EEZEO zinc gluconate lozenges, used to reduce the duration and severity of symptoms of the common cold. In August 2011, the Company launched Cold-EEZE Oral Spray.

0.140 s

+0.005 (+3.70%)
Range 0.129 - 0.140   (8.53%)
Open 0.134
Previous Close 0.135
Bid Price 9.340
Bid Volume 11
Ask Price 9.400
Ask Volume 11
Volume 4,799,520
Value -
Remark s
Delayed prices. Updated at 05 Dec 2025 05:00.
Data powered by
View All Events

About ProPhase Labs

ProPhase Labs, Inc. is a manufacturer, marketer and distributor of a ranges of homeopathic and health products that are offered to the general public. The Company is also engaged in the research and development of potential over-the-counter (OTC) drugs, natural base health products along with supplements, personal care and cosmeceutical products. The Company's primary business is manufacturing, distribution, marketing and selling of OTC cold remedy products to consumers through food, multi-outlet pharmacy and chain drug stores, wholesalers and mass merchandisers. The Company's brand is Cold-EEZEO Cold Remedy and the Company's principal product is Cold-EEZEO zinc gluconate lozenges, used to reduce the duration and severity of symptoms of the common cold. In August 2011, the Company launched Cold-EEZE Oral Spray.

Top Contributors

USNews avatar
347
Followers 272
Posts 1283231

Loading Chart...

Please login to view stock data and analysis